Bleeding Risk Following Percutaneous Coronary Intervention in Patients with Diabetes Prescribed Dual Anti-platelet Therapy

BACKGROUND: Patients with diabetes (DM) experience higher rates of in-stent restenosis and greater benefit from DES implant at the time of PCI, necessitating prolonged dual anti-platelet therapy (DAPT). While DAPT reduces risk of ischemic events post-PCI, it also increases risk of bleeding. Whether...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Am Heart J
Hoofdauteurs: Grodzinsky, Anna, Arnold, Suzanne V., Wang, Tracy Y., Sharma, Praneet, Gosch, Kensey, Jones, Philip G., Bhatt, Deepak L., Steg, Philippe Gabriel, McGuire, Darren K., Cohen, David J., Spertus, John A., Chhatriwalla, Adnan K., Lind, Marcus, Graham, Garth, Kosiborod, Mikhail
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5357237/
https://ncbi.nlm.nih.gov/pubmed/27914490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2016.09.010
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items